Product NDC: | 63323-327 |
Proprietary Name: | Nafcillin |
Non Proprietary Name: | NAFCILLIN SODIUM |
Active Ingredient(s): | 1 g/4mL & nbsp; NAFCILLIN SODIUM |
Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
Dosage Form(s): | POWDER, FOR SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 63323-327 |
Labeler Name: | APP Pharmaceuticals, LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA090002 |
Marketing Category: | ANDA |
Start Marketing Date: | 20110630 |
Package NDC: | 63323-327-10 |
Package Description: | 10 VIAL in 1 CARTON (63323-327-10) > 4 mL in 1 VIAL |
NDC Code | 63323-327-10 |
Proprietary Name | Nafcillin |
Package Description | 10 VIAL in 1 CARTON (63323-327-10) > 4 mL in 1 VIAL |
Product NDC | 63323-327 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | NAFCILLIN SODIUM |
Dosage Form Name | POWDER, FOR SOLUTION |
Route Name | INTRAMUSCULAR; INTRAVENOUS |
Start Marketing Date | 20110630 |
Marketing Category Name | ANDA |
Labeler Name | APP Pharmaceuticals, LLC |
Substance Name | NAFCILLIN SODIUM |
Strength Number | 1 |
Strength Unit | g/4mL |
Pharmaceutical Classes | Penicillin-class Antibacterial [EPC],Penicillins [Chemical/Ingredient] |